Investment Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,057
| Closed | -$203K | – | 155 |
|
|
2024
Q3 | $203K | Sell |
2,057
-130
| -6% | -$12.8K | 0.08% | 144 |
|
|
2024
Q2 | $203K | Sell |
2,187
-26
| -1% | -$2.41K | 0.09% | 138 |
|
|
2024
Q1 | $210K | Buy |
+2,213
| New | +$210K | 0.1% | 136 |
|
|
2023
Q1 | – | Sell |
-3,410
| Closed | -$283K | – | 144 |
|
|
2022
Q4 | $283K | Sell |
3,410
-826
| -19% | -$68.6K | 0.15% | 117 |
|
|
2022
Q3 | $336K | Sell |
4,236
-1,747
| -29% | -$139K | 0.1% | 176 |
|
|
2022
Q2 | $444K | Buy |
5,983
+50
| +0.8% | +$3.71K | 0.22% | 93 |
|
|
2022
Q1 | $533K | Sell |
5,933
-165
| -3% | -$14.8K | 0.23% | 87 |
|
|
2021
Q4 | $683K | Buy |
6,098
+1,373
| +29% | +$154K | 0.28% | 78 |
|
|
2021
Q3 | $594K | Buy |
4,725
+1,372
| +41% | +$172K | 0.27% | 80 |
|
|
2021
Q2 | $454K | Buy |
3,353
+1,056
| +46% | +$143K | 0.21% | 93 |
|
|
2021
Q1 | $312K | Buy |
2,297
+709
| +45% | +$96.3K | 0.15% | 117 |
|
|
2020
Q4 | $224K | Buy |
+1,588
| New | +$224K | 0.12% | 135 |
|